{"component": "definition", "props": {"groups": [{"snippet": "means Collaboration Know-How and Collaboration Patents.", "snippet_links": [{"key": "collaboration-patents", "type": "clause", "offset": [33, 54]}], "samples": [{"hash": "b0C5DbTvVgI", "uri": "/contracts/b0C5DbTvVgI#collaboration-ip", "label": "Research Collaboration and License Agreement (TScan Therapeutics, Inc.)", "score": 34.6043815613, "published": true}, {"hash": "aGgWzLLfW8Q", "uri": "/contracts/aGgWzLLfW8Q#collaboration-ip", "label": "Collaboration and License Agreement (CytomX Therapeutics, Inc.)", "score": 34.2320327759, "published": true}, {"hash": "d6OOE2EVjnJ", "uri": "/contracts/d6OOE2EVjnJ#collaboration-ip", "label": "Research Collaboration and Option Agreement (Felicitex Therapeutics Inc.)", "score": 33.6050643921, "published": true}], "size": 75, "hash": "4a51bb38af18a9dbae45fc0fb8175c97", "id": 1}, {"snippet": "means (a) any and all ideas, information, Know-How, data research results, writings, inventions, discoveries, modifications, enhancements, derivatives, new uses, developments, techniques, materials, compounds, products, designs, processes or other technology or intellectual property, whether or not patentable or copyrightable, in each case, that is not an improvement to then-existing Acceleron Technology, Celgene Technology, or Joint Technology and is developed by either Party, its Affiliates or Third Parties acting on their behalf while performing activities under this Agreement, and (b) all Patent Rights and other intellectual property rights in any of the foregoing.", "snippet_links": [{"key": "research-results", "type": "definition", "offset": [57, 73]}, {"key": "new-uses", "type": "definition", "offset": [152, 160]}, {"key": "other-technology", "type": "clause", "offset": [242, 258]}, {"key": "each-case", "type": "definition", "offset": [332, 341]}, {"key": "acceleron-technology", "type": "definition", "offset": [387, 407]}, {"key": "celgene-technology", "type": "definition", "offset": [409, 427]}, {"key": "joint-technology", "type": "definition", "offset": [432, 448]}, {"key": "by-either-party", "type": "clause", "offset": [466, 481]}, {"key": "third-parties", "type": "clause", "offset": [501, 514]}, {"key": "activities-under-this-agreement", "type": "clause", "offset": [555, 586]}, {"key": "patent-rights", "type": "clause", "offset": [600, 613]}, {"key": "other-intellectual-property-rights", "type": "clause", "offset": [618, 652]}, {"key": "the-foregoing", "type": "definition", "offset": [663, 676]}], "samples": [{"hash": "lJFR1SFBppP", "uri": "/contracts/lJFR1SFBppP#collaboration-ip", "label": "Collaboration, License and Option Agreement (Acceleron Pharma Inc)", "score": 32.5920600891, "published": true}, {"hash": "gxoULYhEMZI", "uri": "/contracts/gxoULYhEMZI#collaboration-ip", "label": "Collaboration, License and Option Agreement (Acceleron Pharma Inc)", "score": 29.5831623077, "published": true}, {"hash": "eey3UE3QyYT", "uri": "/contracts/eey3UE3QyYT#collaboration-ip", "label": "Collaboration, License and Option Agreement (Acceleron Pharma Inc)", "score": 28.8494186401, "published": true}], "size": 18, "hash": "6b4ac65fe19bd630e69ca6f0310494c4", "id": 2}, {"snippet": "means, collectively, Alnylam Collaboration IP, Inex Collaboration IP and Joint Collaboration IP.", "snippet_links": [{"key": "alnylam-collaboration-ip", "type": "definition", "offset": [21, 45]}, {"key": "inex-collaboration-ip", "type": "definition", "offset": [47, 68]}, {"key": "joint-collaboration-ip", "type": "clause", "offset": [73, 95]}], "samples": [{"hash": "iAP6vBQXNDS", "uri": "/contracts/iAP6vBQXNDS#collaboration-ip", "label": "License and Collaboration Agreement (Regulus Therapeutics Inc.)", "score": 32.364818573, "published": true}, {"hash": "3qUkQUY5P8p", "uri": "/contracts/3qUkQUY5P8p#collaboration-ip", "label": "License and Collaboration Agreement (Regulus Therapeutics Inc.)", "score": 23.6255989075, "published": true}, {"hash": "f0zJrW1oLsl", "uri": "/contracts/f0zJrW1oLsl#collaboration-ip", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "size": 14, "hash": "8e299e11c67b04b560e652aae4f8a001", "id": 3}, {"snippet": "means, with respect to a Party, any inventions, technology, know-how, trade secrets, and any other intellectual property, whether patentable or not, that has been conceived or reduced to practice pursuant to this Agreement, a Statement of Work hereunder or that is related to a Project. Subject to the restrictions set forth in Section 4.1, Sponsor, shall own all right, title and interest in and to the Collaboration IP and the Results directly related to each Project for which they are a Sponsor, regardless of inventorship.", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "a-party", "type": "clause", "offset": [23, 30]}, {"key": "trade-secrets", "type": "clause", "offset": [70, 83]}, {"key": "other-intellectual-property", "type": "definition", "offset": [93, 120]}, {"key": "to-practice", "type": "clause", "offset": [184, 195]}, {"key": "pursuant-to-this-agreement", "type": "clause", "offset": [196, 222]}, {"key": "statement-of-work", "type": "definition", "offset": [226, 243]}, {"key": "the-restrictions", "type": "clause", "offset": [298, 314]}, {"key": "section-41", "type": "clause", "offset": [328, 339]}, {"key": "title-and-interest", "type": "clause", "offset": [371, 389]}, {"key": "the-collaboration", "type": "clause", "offset": [400, 417]}, {"key": "directly-related-to", "type": "definition", "offset": [437, 456]}], "samples": [{"hash": "iF3vKhDS5Go", "uri": "/contracts/iF3vKhDS5Go#collaboration-ip", "label": "Service Framework Agreement (Dyadic International Inc)", "score": 34.8507881165, "published": true}, {"hash": "huWL8ydOow3", "uri": "/contracts/huWL8ydOow3#collaboration-ip", "label": "Service Framework Agreement (Dyadic International Inc)", "score": 30.0349082947, "published": true}, {"hash": "hX1C38odock", "uri": "/contracts/hX1C38odock#collaboration-ip", "label": "Service Framework Agreement (Dyadic International Inc)", "score": 29.8432579041, "published": true}], "size": 11, "hash": "4e33bb4f6385a4f80575a14c32b955e7", "id": 4}, {"snippet": "means [***].", "snippet_links": [], "samples": [{"hash": "9uAozd7afCt", "uri": "/contracts/9uAozd7afCt#collaboration-ip", "label": "Research Collaboration Agreement (ArriVent BioPharma, Inc.)", "score": 35.86926651, "published": true}, {"hash": "74vbN85LtfB", "uri": "/contracts/74vbN85LtfB#collaboration-ip", "label": "License and Collaboration Agreement (BioNTech SE)", "score": 35.2149200439, "published": true}, {"hash": "cil9q5wggq5", "uri": "/contracts/cil9q5wggq5#collaboration-ip", "label": "License and Collaboration Agreement (BioNTech SE)", "score": 34.2149200439, "published": true}], "size": 10, "hash": "42145ccc68badf480a8ed917c57dd5fc", "id": 5}, {"snippet": "means the Collaboration Know-How and Collaboration Patents.", "snippet_links": [{"key": "the-collaboration", "type": "clause", "offset": [6, 23]}, {"key": "collaboration-patents", "type": "clause", "offset": [37, 58]}], "samples": [{"hash": "gb4D5hd4AB7", "uri": "/contracts/gb4D5hd4AB7#collaboration-ip", "label": "Research Collaboration and License Agreement (Century Therapeutics, Inc.)", "score": 33.2053375244, "published": true}, {"hash": "3RPQeY6TZ8v", "uri": "/contracts/3RPQeY6TZ8v#collaboration-ip", "label": "Research Collaboration and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "ldT3Ke7Ilwg", "uri": "/contracts/ldT3Ke7Ilwg#collaboration-ip", "label": "Master Collaboration Agreement (Scholar Rock Holding Corp)", "score": 29.9774131775, "published": true}], "size": 9, "hash": "cbbc10c21a6cf82b1155b17196a9c0ed", "id": 6}, {"snippet": "means, collectively:", "snippet_links": [], "samples": [{"hash": "4We0rmbDcwA", "uri": "/contracts/4We0rmbDcwA#collaboration-ip", "label": "Master Collaboration Agreement (Ikena Oncology, Inc.)", "score": 32.1731681824, "published": true}, {"hash": "2iRVKKHzUGU", "uri": "/contracts/2iRVKKHzUGU#collaboration-ip", "label": "Collaboration and License Agreement (Atreca, Inc.)", "score": 31.6119098663, "published": true}, {"hash": "62quUrAsOsV", "uri": "/contracts/62quUrAsOsV#collaboration-ip", "label": "Master Research and Collaboration Agreement (Juno Therapeutics, Inc.)", "score": 26.6153316498, "published": true}], "size": 9, "hash": "eee964bd0f0c986398e6e5688c5da079", "id": 7}, {"snippet": "has the meaning set forth in Section 10.1.", "snippet_links": [], "samples": [{"hash": "UspYc1o2y4", "uri": "/contracts/UspYc1o2y4#collaboration-ip", "label": "Research Collaboration, Option and License Agreement (Praxis Precision Medicines, Inc.)", "score": 31.7323741913, "published": true}, {"hash": "kMr3tDrJAey", "uri": "/contracts/kMr3tDrJAey#collaboration-ip", "label": "Research Collaboration, Option and License Agreement (Praxis Precision Medicines, Inc.)", "score": 31.6557159424, "published": true}, {"hash": "eBewJuh4R2D", "uri": "/contracts/eBewJuh4R2D#collaboration-ip", "label": "Research Collaboration, Option and License Agreement (Praxis Precision Medicines, Inc.)", "score": 31.5544147491, "published": true}], "size": 8, "hash": "a640614616de972a98decbcf85766209", "id": 8}, {"snippet": "means, collectively, the Collaboration Patents and Collaboration Know-How.", "snippet_links": [{"key": "collaboration-patents", "type": "clause", "offset": [25, 46]}], "samples": [{"hash": "hl8C5s7umYE", "uri": "/contracts/hl8C5s7umYE#collaboration-ip", "label": "Collaboration and License Agreement (Editas Medicine, Inc.)", "score": 31.1519508362, "published": true}, {"hash": "eGtJgs6J69A", "uri": "/contracts/eGtJgs6J69A#collaboration-ip", "label": "Collaboration and License Agreement (Fate Therapeutics Inc)", "score": 26.8453121185, "published": true}, {"hash": "l1VRCbF8pxZ", "uri": "/contracts/l1VRCbF8pxZ#collaboration-ip", "label": "Collaboration and License Agreement (Fate Therapeutics Inc)", "score": 26.5906906128, "published": true}], "size": 5, "hash": "40f4f71a29982bda33acc52c1e15292d", "id": 9}, {"snippet": "means (i) all Intellectual Property rights in Collaboration Technology, which Intellectual Property rights were created by the parties' Listed Representatives (solely or jointly) in the course of working on the Collaboration and (ii) all Intellectual Property of either party conceived or created by or for either party (\"Party\") prior to the termination or *** Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. Omitted portions have been filed separately with the Commission. expiration of the Collaboration based on the other party's Confidential Information disclosed to such Party in connection with the Collaboration.", "snippet_links": [{"key": "rights-in-collaboration-technology", "type": "clause", "offset": [36, 70]}, {"key": "by-the-parties", "type": "clause", "offset": [120, 134]}, {"key": "listed-representatives", "type": "definition", "offset": [136, 158]}, {"key": "in-the-course-of", "type": "definition", "offset": [179, 195]}, {"key": "the-collaboration", "type": "clause", "offset": [207, 224]}, {"key": "either-party", "type": "definition", "offset": [263, 275]}, {"key": "the-termination", "type": "clause", "offset": [339, 354]}, {"key": "confidential-treatment-requested", "type": "definition", "offset": [362, 394]}, {"key": "pursuant-to-a", "type": "clause", "offset": [395, 408]}, {"key": "request-for-confidential-treatment", "type": "definition", "offset": [409, 443]}, {"key": "the-securities-and-exchange-commission", "type": "clause", "offset": [455, 493]}, {"key": "the-commission", "type": "clause", "offset": [544, 558]}, {"key": "expiration-of-the", "type": "clause", "offset": [560, 577]}, {"key": "based-on", "type": "clause", "offset": [592, 600]}, {"key": "other-party", "type": "clause", "offset": [605, 616]}, {"key": "information-disclosed", "type": "clause", "offset": [632, 653]}, {"key": "such-party", "type": "clause", "offset": [657, 667]}, {"key": "in-connection-with", "type": "clause", "offset": [668, 686]}], "samples": [{"hash": "f6tSAzWl7Ep", "uri": "/contracts/f6tSAzWl7Ep#collaboration-ip", "label": "Cooperative Development Agreement (Nanosys Inc)", "score": 18.0, "published": true}, {"hash": "dvAEsoweimB", "uri": "/contracts/dvAEsoweimB#collaboration-ip", "label": "Cooperative Development Agreement (Nanosys Inc)", "score": 18.0, "published": true}, {"hash": "dW0002i2zGT", "uri": "/contracts/dW0002i2zGT#collaboration-ip", "label": "Cooperative Development Agreement (Nanosys Inc)", "score": 18.0, "published": true}], "size": 5, "hash": "f1c0d417d79bf78b7c170ee80b0815ce", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZY29sbGFib3JhdGlvbi1pcCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Collaboration IP", "snippet": "means Collaboration Know-How and Collaboration Patents.", "size": 260, "id": "collaboration-ip", "examples": ["Subject to the rights, licenses and restrictions contained in this Agreement, each Party may exercise its ownership rights in and to <strong>Collaboration IP</strong>, either by itself or through an Affiliate, Subcontractor, or Sublicensee.", "Similarly, in the event Licensor wishes to assign its rights and interest under the Licensed IP and <strong>Collaboration IP</strong> that is licensed to Licensee hereunder to an Affiliate or Third Party, it shall use Commercially Reasonable Efforts to also assign all its rights under this Agreement to such Affiliate or Third Party except where such Licensed IP or <strong>Collaboration IP</strong> could also be utilized for the exploitation of other compounds or products."], "related": [["developed-technology", "Developed Technology", "Developed Technology"], ["program-technology", "Program Technology", "Program Technology"], ["collaboration-patent-rights", "Collaboration Patent Rights", "Collaboration Patent Rights"], ["collaboration-patents", "Collaboration Patents", "Collaboration Patents"], ["collaboration-know-how", "Collaboration Know-How", "Collaboration Know-How"]], "related_snippets": [], "updated": "2026-03-29T04:25:46+00:00"}, "json": true, "cursor": ""}}